Santarus, Inc. (SNTS) Tops Q2 EPS by 4c; Guides FY11 Revs
Tweet
Share
E-mailGet Alerts SNTS Hot Sheet
Join SI Premium – FREE
Santarus, Inc. (NASDAQ: SNTS) reported Q2 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $26.6 million versus the consensus estimate of $25.1 million.
Sees FY2011 revenue of $110 million, versus the consensus of $107.77 million.
Sees FY2011 revenue of $110 million, versus the consensus of $107.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- OmniAb raises 2026 cash guidance on licensing activity
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
